Rodgers Brothers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $51.6M | Sell |
56,132
-812
| -1% | -$823K | 5.97% | 2 |
|
|
2025
Q4 | $61.2M | Sell |
56,944
-1,867
| -3% | -$1.79M | 7.33% | 2 |
|
|
2025
Q3 | $44.9M | Sell |
58,811
-609
| -1% | -$453K | 5.53% | 2 |
|
|
2025
Q2 | $46.3M | Sell |
59,420
-490
| -0.8% | -$381K | 5.85% | 1 |
|
|
2025
Q1 | $49.5M | Sell |
59,910
-742
| -1% | -$617K | 6.59% | 1 |
|
|
2024
Q4 | $46.8M | Sell |
60,652
-481
| -0.8% | -$398K | 6.11% | 1 |
|
|
2024
Q3 | $54.2M | Sell |
61,133
-450
| -0.7% | -$405K | 6.88% | 1 |
|
|
2024
Q2 | $55.8M | Sell |
61,583
-1,214
| -2% | -$971K | 7.55% | 1 |
|
|
2024
Q1 | $48.9M | Sell |
62,797
-2,640
| -4% | -$1.88M | 6.67% | 1 |
|
|
2023
Q4 | $38.1M | Sell |
65,437
-2,155
| -3% | -$1.26M | 6.02% | 1 |
|
|
2023
Q3 | $36.3M | Sell |
67,592
-292
| -0.4% | -$150K | 6.2% | 1 |
|
|
2023
Q2 | $31.8M | Sell |
67,884
-606
| -0.9% | -$254K | 5.61% | 1 |
|
|
2023
Q1 | $23.5M | Sell |
68,490
-340
| -0.5% | -$115K | 4.52% | 1 |
|
|
2022
Q4 | $25.2M | Sell |
68,830
-1,683
| -2% | -$597K | 5.06% | 1 |
|
|
2022
Q3 | $22.8M | Sell |
70,513
-6,360
| -8% | -$2.02M | 4.86% | 1 |
|
|
2022
Q2 | $24.9M | Sell |
76,873
-6,200
| -7% | -$1.86M | 4.93% | 1 |
|
|
2022
Q1 | $23.8M | Sell |
83,073
-1,130
| -1% | -$291K | 4.27% | 1 |
|
|
2021
Q4 | $23.3M | Sell |
84,203
-173
| -0.2% | -$43.9K | 4.14% | 1 |
|
|
2021
Q3 | $19.5M | Buy |
84,376
+238
| +0.3% | +$58.7K | 3.89% | 2 |
|
|
2021
Q2 | $19.3M | Sell |
84,138
-775
| -0.9% | -$156K | 3.7% | 2 |
|
|
2021
Q1 | $15.9M | Buy |
84,913
+465
| +0.6% | +$91K | 3.28% | 2 |
|
|
2020
Q4 | $14.3M | Sell |
84,448
-1,200
| -1% | -$179K | 3.26% | 4 |
|
|
2020
Q3 | $12.7M | Sell |
85,648
-830
| -1% | -$128K | 3.28% | 3 |
|
|
2020
Q2 | $14.2M | Sell |
86,478
-6,037
| -7% | -$927K | 3.85% | 2 |
|
|
2020
Q1 | $12.8M | Sell |
92,515
-1,474
| -2% | -$203K | 4.07% | 1 |
|
|
2019
Q4 | $12.4M | Sell |
93,989
-698
| -0.7% | -$80.9K | 3.21% | 3 |
|
|
2019
Q3 | $10.6M | Buy |
94,687
+8,376
| +10% | +$933K | 2.93% | 3 |
|
|
2019
Q2 | $9.56M | Buy |
86,311
+2,020
| +2% | +$238K | 2.66% | 4 |
|
|
2019
Q1 | $10.9M | Sell |
84,291
-1,450
| -2% | -$176K | 3.11% | 3 |
|
|
2018
Q4 | $9.92M | Buy |
85,741
+25
| +0% | +$2.79K | 3.19% | 3 |
|
|
2018
Q3 | $9.2M | Sell |
85,716
-8,156
| -9% | -$815K | 2.64% | 4 |
|
|
2018
Q2 | $8.01M | Buy |
93,872
+52
| +0.1% | +$4.27K | 2.44% | 5 |
|
|
2018
Q1 | $7.26M | Buy |
93,820
+6,080
| +7% | +$489K | 2.37% | 5 |
|
|
2017
Q4 | $7.41M | Sell |
87,740
-323
| -0.4% | -$27.5K | 2.42% | 5 |
|
|
2017
Q3 | $7.53M | Buy |
88,063
+52
| +0.1% | +$4.26K | 2.65% | 5 |
|
|
2017
Q2 | $7.24M | Sell |
88,011
-98
| -0.1% | -$8K | 2.67% | 5 |
|
|
2017
Q1 | $7.41M | Sell |
88,109
-698
| -0.8% | -$55.9K | 2.8% | 4 |
|
|
2016
Q4 | $6.53M | Buy |
88,807
+3,562
| +4% | +$265K | 2.56% | 7 |
|
|
2016
Q3 | $6.84M | Buy |
85,245
+152
| +0.2% | +$12.2K | 2.75% | 5 |
|
|
2016
Q2 | $6.7M | Buy |
85,093
+4,850
| +6% | +$365K | 2.76% | 7 |
|
|
2016
Q1 | $5.78M | Sell |
80,243
-200
| -0.2% | -$15.1K | 2.51% | 7 |
|
|
2015
Q4 | $6.78M | Sell |
80,443
-2,609
| -3% | -$217K | 3.17% | 4 |
|
|
2015
Q3 | $6.95M | Sell |
83,052
-696
| -0.8% | -$58.8K | 3.49% | 2 |
|
|
2015
Q2 | $6.99M | Sell |
83,748
-2,135
| -2% | -$163K | 3.31% | 2 |
|
|
2015
Q1 | $6.24M | Sell |
85,883
-975
| -1% | -$69.4K | 3.05% | 4 |
|
|
2014
Q4 | $5.99M | Sell |
86,858
-593
| -0.7% | -$40K | 2.99% | 6 |
|
|
2014
Q3 | $5.67M | Sell |
87,451
-185
| -0.2% | -$11.7K | 2.96% | 6 |
|
|
2014
Q2 | $5.45M | Sell |
87,636
-3,600
| -4% | -$215K | 2.7% | 6 |
|
|
2014
Q1 | $5.37M | Sell |
91,236
-100
| -0.1% | -$5.58K | 2.59% | 6 |
|
|
2013
Q4 | $4.66M | Buy |
91,336
+400
| +0.4% | +$20K | 2.31% | 7 |
|
|
2013
Q3 | $4.58M | Buy |
90,936
+3,635
| +4% | +$190K | 2.51% | 6 |
|
|
2013
Q2 | $4.29M | Buy |
+87,301
| New | +$4.75M | 2.56% | 7 |
|
Other funds holding LLY
VCM
VPM
Rodgers Brothers's LLY Position: Q1 2026 in Review
Rodgers Brothers reduced its Eli Lilly (LLY) stake by 1.4% in Q1 2026, selling an estimated $823K and leaving 56,132 shares worth $51.6M. The position accounts for 5.97% of the portfolio, ranked #2.
Rodgers Brothers first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $61.2M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Rodgers Brothers held 56,132 shares of Eli Lilly worth $51.6M as of Q1 2026.
- Rodgers Brothers sold 812 Eli Lilly shares in Q1 2026, an estimated $823K.
- Eli Lilly made up 5.97% of Rodgers Brothers's portfolio in Q1 2026, its #2 holding.
- Rodgers Brothers first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Rodgers Brothers's Eli Lilly position peaked at $61.2M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Rodgers Brothers's 13F filing for Q1 2026, filed 14 May 2026.